Quarterly report pursuant to Section 13 or 15(d)

Note 14 - Subsequent Events (Details Textual)

v3.21.1
Note 14 - Subsequent Events (Details Textual) - USD ($)
$ in Thousands
9 Months Ended
Apr. 06, 2021
Apr. 02, 2021
Oct. 20, 2020
Mar. 31, 2021
Mar. 31, 2020
Payments to Acquire Businesses, Net of Cash Acquired, Total       $ 9,765 $ (0)
Changzhou Eminence Biotechnology [Member]          
Payments to Acquire Businesses, Net of Cash Acquired, Total     $ 9,765    
Subsequent Event [Member] | Acquisition of Asuragen, Inc. [Member]          
Payments to Acquire Businesses, Net of Cash Acquired, Total $ 215,000        
Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High $ 105,000        
Subsequent Event [Member] | Changzhou Eminence Biotechnology [Member]          
Payments to Acquire Businesses, Gross   $ 6,000      
Business Combination, Step Acquisition, Equity Interest in Acquiree, including Subsequent Acquisition, Percentage, Total   57.42%